HUT59937A - Process for producing aromataze inhibitors containing 2-beta,- 19-ethylene-bridge and process for producing pharmaceutical compositions containing them as active components - Google Patents

Process for producing aromataze inhibitors containing 2-beta,- 19-ethylene-bridge and process for producing pharmaceutical compositions containing them as active components

Info

Publication number
HUT59937A
HUT59937A HU913739A HU373991A HUT59937A HU T59937 A HUT59937 A HU T59937A HU 913739 A HU913739 A HU 913739A HU 373991 A HU373991 A HU 373991A HU T59937 A HUT59937 A HU T59937A
Authority
HU
Hungary
Prior art keywords
producing
ethylene
aromataze
beta
bridge
Prior art date
Application number
HU913739A
Other languages
English (en)
Other versions
HU210830B (en
HU913739D0 (en
Inventor
John O'neal Johnston
Norton Paul Peet
Joseph Paul Burkhart
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of HU913739D0 publication Critical patent/HU913739D0/hu
Publication of HUT59937A publication Critical patent/HUT59937A/hu
Publication of HU210830B publication Critical patent/HU210830B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU913739A 1990-11-30 1991-11-29 Process for the preparation of 2beta, 19-ethylene bridged androstene derivative as aromatase inhibitor and pharmaceutical composition containing the same HU210830B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/621,184 US5166201A (en) 1990-11-30 1990-11-30 2β,19-ethylene bridged steroids as aromatase inhibitors

Publications (3)

Publication Number Publication Date
HU913739D0 HU913739D0 (en) 1992-02-28
HUT59937A true HUT59937A (en) 1992-07-28
HU210830B HU210830B (en) 1995-08-28

Family

ID=24489093

Family Applications (1)

Application Number Title Priority Date Filing Date
HU913739A HU210830B (en) 1990-11-30 1991-11-29 Process for the preparation of 2beta, 19-ethylene bridged androstene derivative as aromatase inhibitor and pharmaceutical composition containing the same

Country Status (20)

Country Link
US (1) US5166201A (hu)
EP (1) EP0488383B1 (hu)
JP (1) JP3143876B2 (hu)
KR (1) KR100190776B1 (hu)
CN (1) CN1033975C (hu)
AT (1) ATE142639T1 (hu)
AU (1) AU635444B2 (hu)
CA (1) CA2056638C (hu)
DE (1) DE69122048T2 (hu)
DK (1) DK0488383T3 (hu)
ES (1) ES2094183T3 (hu)
FI (1) FI102073B (hu)
GR (1) GR3021981T3 (hu)
HU (1) HU210830B (hu)
IE (1) IE914168A1 (hu)
IL (1) IL100196A (hu)
NO (1) NO180304C (hu)
NZ (1) NZ240738A (hu)
PT (1) PT99661B (hu)
ZA (1) ZA919296B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510862A1 (de) * 1995-03-16 1996-09-19 Schering Ag Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
EP1889198B1 (en) 2005-04-28 2014-11-26 Proteus Digital Health, Inc. Pharma-informatics system
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3627756A (en) * 1970-04-23 1971-12-14 Searle & Co N-dialkylaminoalkyl-n-(2{62 ,19-epoxy-5{60 -androstan-17{62 -yl)amines/formamides and 3{60 -halo derivatives thereof
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
US4882322A (en) * 1988-10-27 1989-11-21 Merrell Dow Pharmaceuticals Inc. 3β,17β-hydroxy-substituted steroids and related steroidal compounds

Also Published As

Publication number Publication date
US5166201A (en) 1992-11-24
FI102073B1 (fi) 1998-10-15
IE914168A1 (en) 1992-06-03
ATE142639T1 (de) 1996-09-15
KR100190776B1 (ko) 1999-06-01
CA2056638A1 (en) 1992-05-31
IL100196A (en) 1996-03-31
NZ240738A (en) 1993-11-25
EP0488383B1 (en) 1996-09-11
ES2094183T3 (es) 1997-01-16
JPH04290898A (ja) 1992-10-15
PT99661B (pt) 1999-05-31
NO914710D0 (no) 1991-11-29
DE69122048T2 (de) 1997-02-20
NO180304B (no) 1996-12-16
FI102073B (fi) 1998-10-15
EP0488383A1 (en) 1992-06-03
FI915623A (fi) 1992-05-31
NO914710L (no) 1992-06-01
CA2056638C (en) 2002-03-05
FI915623A0 (fi) 1991-11-28
HU210830B (en) 1995-08-28
DK0488383T3 (da) 1996-09-30
NO180304C (no) 1997-04-02
IL100196A0 (en) 1992-08-18
KR920009842A (ko) 1992-06-25
ZA919296B (en) 1992-08-26
PT99661A (pt) 1992-10-30
DE69122048D1 (de) 1996-10-17
CN1033975C (zh) 1997-02-05
GR3021981T3 (en) 1997-03-31
HU913739D0 (en) 1992-02-28
AU635444B2 (en) 1993-03-18
AU8812891A (en) 1992-06-04
CN1061974A (zh) 1992-06-17
JP3143876B2 (ja) 2001-03-07

Similar Documents

Publication Publication Date Title
IL108087A (en) 2-substituted-3-azaindolyl- acrylonitrile and 3-(azaindolyl-methylene) oxindole derivatives, process for their preparation and pharmaceutical compositions containing them
AU1843297A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
IL127296A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
ES8706165A1 (es) Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida.
NO20002676L (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
HUT59937A (en) Process for producing aromataze inhibitors containing 2-beta,- 19-ethylene-bridge and process for producing pharmaceutical compositions containing them as active components
DE3472791D1 (en) Gamma-butyrolactone derivatives, process for preparing the same and immunomodulating compositions containing the same as active ingredients
YU3099A (sh) Novi derivati eritromicina, postupak za njihovo dobijanje i njihova primena
HUT39601A (en) Process for producing synergistic contraceptive compositions
HUT64365A (en) Process for steroid aromatase inhibitors containing 2-beta, 19-methylene-amino bridge and pharmaceutical preparatives containing them
CA2309485A1 (en) New 4-arylpiperidine derivatives for the treatment of pruritus
ES8802034A1 (es) Procedimiento de obtencion de nuevos derivados nitrogenados, penta o hexa ciclicos sustituidos por un radical aminado
ES8505685A1 (es) Un procedimiento para preparar compuestos de espiro (2h-1,4-benzodioxepin-3(5h)4'-piperidina y -3'-pirrolidina)
NZ237559A (en) Halogenoethyl steroid derivatives and pharmaceutical compositions
ES8304989A1 (es) Mejoras introducidas en un procedimiento para la preparacion hidroximidatos y tiolhidroximidatos heterobiciclicos y de- rivados ester carbomatos de los mismos.
CY1742A (en) Mitomycin analogs a process for preparing them and pharmaceutical compositions
ES8206503A1 (es) Procedimiento para la obtencion de a-butirolactonas insatu- radas,ab-sustituidas
JPS52131580A (en) N-substituted pyridinium-2-sulfonylimines, containing same as active ingredient
NZ329604A (en) Isoxazole derivatives substituted by an amino, guanidinyl or azacycloalkyl-oxy, -sulphinyl or -sulphenyl group, pharmaceutical compositions comprising them
DE3065162D1 (en) Methyl (5-(2-thienylhydroxymethyl)-1h-benzimidazol-2-yl) carbamate, process for its preparation and compositions containing it

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee